Creative Medical Technology Holdings Inc

This early-stage study tests a new treatment called CELZ-201 for people recently diagnosed with type 1 diabetes. The treatment is given through an artery and aims to see if it is safe and can help control the disease. The study involves 18 adults aged 18-35 who were diagnosed wit…

This study tests an experimental drug called CELZ-201-DDT, given as a shot into the back muscles, for people with long-term lower back pain due to worn-out spinal discs. The goal is to see if it is safe and can reduce pain and improve movement. About 45 adults aged 18 to 80 who h…